CJC-1295 + lpamorelin

The CJC-1295 No DAC + Ipamorelin Blend combines two complementary neuroendocrine growth hormone secretagogues into a single precision-formulated vial. CJC-1295 No DAC (Modified GRF 1-29) acts as a Growth Hormone-Releasing Hormone (GHRH) receptor agonist, while Ipamorelin functions as a selective Ghrelin/Growth Hormone Secretagogue Receptor (GHS-R) agonist. By acting on two distinct signaling pathways simultaneously, this combination is widely utilized in research to study synergistic, pulsatile growth hormone secretion and downstream IGF-1 expression without elevating cortisol or prolactin baseline levels. True Lab Peptides offers this dual blend at an independently verified purity threshold of $\ge$99% for maximum experimental consistency.

Key Research Applications

• Dual-Pathway Secretagogue Research: Engineered to investigate the synergistic interaction between GHRH and GHS-R activation pathways in pituitary cell models.

• Pulsatile Hormone Signaling: Ideal for studying natural, non-desensitizing growth hormone release kinetics and downstream cellular signaling.

• Metabolic & Tissue Response Modeling: Utilized to evaluate extracellular matrix remodeling, cellular longevity pathways, and protein synthesis dynamics.

• Analytical Characterization: Serves as a reliable reference standard for High-Performance Liquid Chromatography (HPLC) and quantitative mass spectrometry workflows.

Technical Specifications

• Product Name: CJC-1295 No DAC + Ipamorelin Blend

• Active Components: Modified GRF 1-29 (CJC-1295 No DAC) | Ipamorelin

• CJC-1295 Formula: $\text{C}_{152}\text{H}_{252}\text{N}_{44}\text{O}_{42}$ (MW: 3367.97 g/mol)

• Ipamorelin Formula: $\text{C}_{38}\text{H}_{49}\text{N}_9\text{O}_5$ (MW: 711.85 g/mol)

• Purity Grade: $\ge$99% (COA-Verified)

• Physical Form: Lyophilized Powder

• Net Quantity: 10 mg total blend per vial (5 mg CJC-1295 No DAC / 5 mg Ipamorelin)

• Category Focus: Neuroendocrine & Cellular Longevity Research

Quality Assurance & Laboratory Protocols

Every batch of the CJC-1295 + Ipamorelin Blend undergoes rigorous third-party analytical validation—including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)—to confirm molecular identity, exact component ratios, and overall purity. Batch-specific Certificates of Analysis (COA) and Safety Data Sheets (SDS) are accessible to ensure full compliance with institutional research standards.

Storage Instructions: Store unopened lyophilized vials in a dry, dark environment at $-20^\circ\text{C}$. Following initial reconstitution for laboratory workflows, maintain under refrigeration at $2^\circ\text{C}$ to $8^\circ\text{C}$. Refer to the product Safety Data Sheet (SDS) for complete chemical handling instructions.

Research Disclaimer: This product is strictly supplied for in vitro, analytical, and laboratory research purposes only. It is not intended for human or veterinary use, consumption, administration, injection, diagnostic procedures, or therapeutic applications.